About this event
Tuesday March 23rd, 2021 - 2pm GMT / 3pm CET / 10 am EDT
Duration: 30 minutes
With developments in our ability to separate single cells from each other and the falling costs of sequencing, single cell analysis can transform our understanding of diseases at the cellular level.
As technology is constantly evolving, it is difficult for anyone to stay on top of what the latest technology does and whether it is right for them or their research question. So how, and where, should we invest for the next era of single cell studies?
This panel features insights from Omer Bayraktar (Group Leader, Wellcome Sanger Institute), Holger Heyn (Team Leader, Single Cell Genomics Group, Centre for Genomic Regulation), Stefania Giacomello (Group Leader, SciLifeLab) and Florian Baumgartner (Senior Product Manager, Visium Spatial Informatics, 10X Genomics).
This webinar has been made possible with the kind support of our partner, 10X Genomics.
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.